The department of clinical pharmacology is a part of SI “Institute endocrinology and metabolism”. We conduct pharmaceutical clinical trials for a wide range of endocrine diseases although the primary focus has been on diabetes research on type 1 and 2 patients. We have been conducting endocrine-related clinical research for close to 20 years and have participated in over 50 trials focusing on the development of new drugs. Our research has resulted in many important drugs coming to market for the benefit of our patient’s health. Our dedicated staff of clinical research coordinators, with over 20 years of combined experience in the execution of these trials, are committed to providing the best environment for patients. People who participate in clinical research receive the benefits of free care of our dedicated physicians to advance their health and the health of all patients with endocrine disorders.
Dr. Zinych has over 15 years cumulative research experience and have worked together as a research team for more than 10 years. She worked last 5 years as Principal Investigator. In addition to their extensive experience, all of our providers (principal investigator and sub-investigators) are on site Monday – Friday and are available to address any questions or concerns research participants have at any time. The PI and all Sub-Investigator are familiar with every single person enrolled, and we hold weekly meetings with the entire team to discuss all study participants, protocol updates, or any other applicable information regarding protocol training and patient safety.
The majority of our study participants are longtime patients of our doctors, and because we have extensive medical histories available, we are able to minimize screen failures. Knowing our patients well also helps ensure that participants will complete the study, as all study participants receive comprehensive care from their regular doctor.
Clinical trials are conducted by department of clinical pharmacology for a variety of conditions, which may include the following: